Efficacy and safety of Janus Kinase Inhibitors versus Traditional DMARDs in moderate to severe Rheumatoid Arthritis. (2025). Revista Eletrônica Acervo Científico, 25, e20772. https://doi.org/10.25248/reac.e20772.2025